Erratum: The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses (Endocrine (2007) 32 (136-142) DOI: 10.1007/s12020-007-9028-8);The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses

Endocrine

Volumn 32, Issue 2, 2007, Pages 136-142

  Tzanela, M ^a   Effremidis, G ^a   Vassiliadi, D ^a   Szabo, A ^a   Gavalas, N ^a   Valatsou, A ^a   Botoula, E ^a   Thalassinos, N C ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Adrenal incidentalomas; Aldosterone to renin ratio; Primary hyperaldosteronism

Indexed keywords

ALDOSTERONE; GLUCOCORTICOID; HYDROCORTISONE; RENIN; BIOLOGICAL MARKER;

ADRENAL INCIDENTALOMA; ADULT; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADRENAL DISEASE; BLOOD; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; HYPERALDOSTERONISM; INCIDENTAL FINDING; MASS SCREENING; METHODOLOGY; MIDDLE AGED;

ADRENAL GLAND DISEASES; ALDOSTERONE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; INCIDENTAL FINDINGS; MALE; MASS SCREENING; MIDDLE AGED; RENIN; SENSITIVITY AND SPECIFICITY;

EID: 40349116213     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9852-3     Document Type: Erratum

References (36)

1. M.M. Grumbach, B.M. Biller, G.D. Braunstein, K.K. Campbell, J.A. Carney, P.A. Godley, E.L. Harris, J.K. Lee, Y.C. Oertel, M.C. Posner, J.A. Schlechte, H.S. Wieand, Management of the clinically inapparent adrenal mass ("incidentaloma") [NIH Conference]. Ann. Inter. Med. 138, 424-429 (2003)
2. G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, S.R. Bornstein, The Clinically Inapparent Adrenal Mass: Update in Diagnosis and management. Endocr. Rev. 25, 309-340 (2004)
3. F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637-644 (2000)
4. G. Bernini, A. Moretti, G. Argenio, A. Salvetti, Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur. J. Endocrinol. 146, 523-529 (2002)
5. W.F. Young, (2007). The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601-610
6. S. Tsagarakis, C. Roboti, P. Kokkoris, V. Vasiliou, C. Alevizaki, N.C. Thalassinos, Elevated post dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin. Endocrinol. 49, 165-171 (1998)
7. N. Valli, B. Catargi, N. Ronci, V. Vergnot, F. Leccia, J.M. Ferriere, G. Chene, N. Grenier, F. Laurent, A. Tabarin, Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur. J. Endocrinol. 144, 401-408 (2001)
8. W.F. Young, Primary hyperaldosteronism: renaissance of a syndrome. Clin. Endocrinol. 66, 607-618 (2007)
9. K. Hiramatsu, T. Yamada, Y. Yukimura, I. Komiya, K. Ichikawa, M. Ishihara, H. Nagata, T. Izumiyama, A screening test to identify aldosterone producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch. Inter. Med. 141, 1589-1593 (1981)
10. N.M. Kaplan, The current epidemic of primary aldosteronism: causes and consequences. J. Hypertens. 22, 863-869 (2004)
11. R.D. Gordon, The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J. Hypertens. 22, 251-255 (2004)
12. J.K. Doig, K.S. Lees, J.L. Reid, The effect of drugs on the renin-angiotensin system in man. in The Renin-angiotensin System, eds. by J.I.S. Robertson, M.G. Nicholls (Merk, London, 1993), pp. 80.1-80.19
13. T.J. McKenna, S.J. Sequeira, A. Heffernan, J. Chambers, S. Cunningham, Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary hyperaldosteronism. J. Clin. Endocrinol. Metabol. 73, 952-957 (1991)
14. A. Tanabe, M. Naruse, S. Takagi, K. Tsuchiya, T. Imaki, K. Takano, Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J. Clin. Endocrinol. Metabol. 88, 2489-2494 (2003)
15. S.J. Duffy, E.S. Biegelsen, R.T. Eberhardt, D.F. Kahn, B.A. Kingwell, J.A. Vita, Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension 46, 707-713 (2005)
16. S.C. Tiu, C.H. Choi, C.C. Shek, Y.w. Ng, F.K.W. Chan, C.M. Ng, A.P. Kong, The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J. Clin. Endocrinol. Metabol. 90, 72-78 (2005)
17. P.E. Plouin, P. Cudek, J.F. Arnal, T.T. Guyene, P. Corvol, Immunoradiometric assay of active renin versus determinations of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis. Horm. Res. 34, 138-141 (1990)
18. F.H. Derkx, C. Steuknkel, M.P. Schalckamp, W. Visser, I.H. Huisveld, M.A. Schalckamp, Immunoreactive renin, prorenin and enzymatically active renin in plasma during pregnancy, and in women taking oral contraceptives. J. Clin. Endocrinol. Metabol. 63, 1008-1015 (1986)
19. C.E. Fardella, L. Mosso, C. Gomez-Sanchez, P. Cortes, J. Soto, L. Gómez, M. Pinto, A. Huete, E. Oestreicher, A. Foradori, J. Monterol, Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J. Clin. Endocrinol. Metabol. 85, 1863-1867. (2000)
20. G.W. Liddle, Tests of pituitary-adrenal suppressability in the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metabol. 20, 1539-1560 (1960)
21. J.A. Hanley, B.I. Mc Neil, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (1982)
22. P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio, Drug effects on Aldosterone/Plasma Renin Activity ratio in primary aldosteronism. Hypertention 40, 897-902 (2002)
23. C. Scifarth, S. Trenkel, H. Schobel, E.G. Hahn, J. Hensen, Influence of antihypertensive medication on aldosterone and renin concentration on in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol. 57, 457-465 (2002)
24. N. Unger, I.L. Schmidt, C. Pitt, M.K. Walz, T. Philipp, K. Mann, S. Petersenn, Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with adrenal mass. Eur. J. Endocrinol. 150, 517-523 (2004)
25. (a) P. Mulatero et al., Trends Endocrinol. Metab. 16,114-119 (2005)
26. P. Mulatero, M. Stowasser, K.F. Loh, C.E. Fardella, R.D. Gordon, L. Mosso, C.E. Gomez-Sanchez, F. Veglio, W.E. Young, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metabol. 154, 865-873 (2004)
27. D.A. Calhoun, M.K. Nishizaka, M.A. Zaman, R.B. Thakkar, P. Weissmann, Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40, 892-896 (2002)
28. W.F. Young Jr Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinol. 144, 2208-2213 (2003)
29. J.S. Williams, G.H. Williams, A. Raji, X. Jeunemaitre, N.J. Brownv P.N. Hopkins, P.R. Conlin, Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J. Hum. Hypertens. 20, 129-136. (2006)
30. C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Rudiger, C. Nickel, F. Beuschlein, Confirmatory testing in normokalaemic primary aldosteronism. Eur. J. Endocrinol. 154, 865-873 (2006)
31. P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, M. Maccario, Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metabol. 91, 2618-2623. (2006)
32. P. Mulatero, R.G. Dluhy, G. Giacchetti, M. Boscaro, F. Veglio, P. Stiewart, Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol. Metab. 16, 114-119 (2005)
33. M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metabol. 87, 998-1003. (2002)
34. S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29, 471-82. (2006)
35. J. Adachi, Y. Hirai, K. Terui, T. Nakano, Y. Fukuda, T. Suda, H. Sasano, Report of 7 Cases of Adrenal Tumors Secreting Both Cortisol and Aldosterone Internal Medicine, vol. 42. (2003) pp. 714-718
36. T. Saito, A. Ikoma, T. Saito, H. Tamemoto, Y. Suminaga, S. Yamada, M. Kawakami, T. Suzuki, H. Sasano, S.E. Ishikawa, Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland. Endocr. J. 54, 287-93 (2007)